Dna X (SONM) Cash from Investing Activities (2018 - 2024)
Dna X filings provide 7 years of Cash from Investing Activities readings, the most recent being -$8000.0 for Q4 2024.
- On a quarterly basis, Cash from Investing Activities rose 33.33% to -$8000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was -$214000.0, a 1326.67% decrease, with the full-year FY2024 number at -$214000.0, down 494.44% from a year prior.
- Cash from Investing Activities hit -$8000.0 in Q4 2024 for Dna X, up from -$137000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $192000.0 in Q4 2020 to a low of -$184000.0 in Q1 2020.
- Median Cash from Investing Activities over the past 5 years was -$9500.0 (2020), compared with a mean of -$19428.6.
- Biggest five-year swings in Cash from Investing Activities: surged 290.1% in 2020 and later crashed 13600.0% in 2024.
- Dna X's Cash from Investing Activities stood at $192000.0 in 2020, then crashed by 113.54% to -$26000.0 in 2021, then surged by 92.31% to -$2000.0 in 2022, then crashed by 500.0% to -$12000.0 in 2023, then soared by 33.33% to -$8000.0 in 2024.
- The last three reported values for Cash from Investing Activities were -$8000.0 (Q4 2024), -$137000.0 (Q3 2024), and -$39000.0 (Q2 2024) per Business Quant data.